Mice which lack PNPLA2 are highly insulin sensitive and resistant to HFD-induced insulin resistance (239)
It transforms a potential point of failure into a reliable, repeatable scientific procedure
Semaglutide has one of the most robust clinical evidence bases of any weight loss medication ever developed
never in the regular trash
BPC-157 Dosage Protocol by Use Case As someone whos been using and recommending BPC-157 for decades, here is the practical framework I share in Living A Fully Optimized Life and the rest of my books and courses: Acute Injuries (Muscle Tears, Tendon Damage, Ligament Strains) 250500 mcg subcutaneously, twice daily (once in the morning and once in the evening) Dosing near the site of injury may provide additional local benefit, though the compound distributes systemically regardless of injection location
Interactions with other medications appear minimal based on available data, but comprehensive medication review is essential before starting BPC-157
